National and Kapodistrian University of Athens
Κλωνοτυπική ανάλυση αλληλουχιών βαριάς αλυσίδας της ανοσοσφαιρίνης (IgH) σε ασθενείς με μακροσφαιριναιμία Waldenström και συσχέτιση με την κλινική τους πορεία και έκβαση
Abstract
dc:descriptionWaldenström’s Macroglobulinemia (WM) cells express a uniqueclonotypic rearrangement of heavy chain immunoglobulin (IgH) genes in eachindividual patient. In this study we characterized IgH genes rearrangementsand somatic hypemutations (SHM) in a cohort of WM patients and weinvestigated any eventual correlation with patients’ clinical features. Thefrequency of the ΜΥD88 L265P mutation was also investigated and correlatedwith the IgH genes rearrangements.36 patients were studied (median age 64y, 19 males and 17 females,symptomatic 72%, asymptomatic 28%) of whom 45%, 39% and 16% werestaged IPSSWM 1, 2 and 3 respectively. Median time to treatment was 13months and median overall survival 61 months. DNA was extracted frompatients’ samples (blood and bone marrow - bone marrow mononuclear cells, bone marrow smears and bone marrow biopsies), IgH VDJ locus wasamplified by PCR using the Biomed-2 strategy, monolclonal VDJ rearrangedfragments were sequenced, and analyzed through the internationalimmunogenetics information system (www.imgt.org). 31 patients’ sampleswere also investigated for ΜΥD88 L265P mutation detection by AS-PCR.The most frequent family usage was IGVH3 (73%) while IGVH3-23and IGVH3-74 segments were used in 24,4% and 18,9% respectively.Somatic hypermutation (>2% deviation from the germline) was seen in all butthree cases (92%). Mean percentage of mutations in all cases, IGVH3 family,IGVH3-23 and IGVH3-74 segments was 7,5%, 8%, 9,4% and 7,5%respectively. CDR3 length was short (≤17 amino acids) in 81% of all cases, although in the three unmutated cases the mean of CDR3 length was 22,3 amino acids. 61,9% of the patients were positive for the ΜΥD88 L265Pmutation. The above-mentioned findings were compared with patients’physical and routine laboratory workup results and no correlations were foundnor was it the case with time to treatment or survival.Conclusions: WM IgH genes’ repertoire differed from those observedin normal B-cells, and other B-cell disorders such as MZL and B-CLL/SLL.IGVH3-23 and IGVH3-74 is overexpressed in WM patients. In addition highIGVH mutation supports a derivation of WM cells from postgerminal centermemory B cells. However the detection of three unmutated (and seldomexpressed in WM) IGHV gene clones in three ΜΥD88 L265P negative WMpatients, which bear long CDR3 segments, could support that thetransformation leading to WM does not target only postgerminal center B cells which bears SHM, and reinforces the existence of biological differencesbetween WM MYD88 mutated and unmutated cases.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2013
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Petrikkos, Loizos
- Πετρίκκος, Λοΐζος
Subjects
dc:subject × 17- Μακροσφαιριναιμία waldenström (MW)
- Βαριά αλυσίδα ανοσοσφαιρίνης (IgH)
- Γονίδιο myd88
- Σωματικές υπερμεταλλάξεις ανοσοσφαιρίνης (ΣΥΜ)
- Μετάλλαξη myd88 l265p
- ΣΥΜ IgH και κλινική πορεία με mw
- Waldenstrom's macroglobulinemia
- Myd88 l265p mutation
- Immunoglobulin heavy chain
- Immunoglobulin somatic hypermutation (SHM)
- IgH SHM and WM patients' clinical course
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Ιατρική Βιοτεχνολογία
- Medical and Health Sciences
- Clinical Medicine
- Medical Biotechnology
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/40225